Diagnostic Value of Leukocyte Count, C-Reactive Protein, and Procalcitonin in Pediatric Liver Transplant Patients
Zerrin Onal1, Elif Turkmen1, Demet Demirkol2
1Department of Pediatric Gastroenterology and Hepatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34126, Turkey.
Insights
Early infection detection after pediatric liver transplant is crucial. Combining body temperature and procalcitonin (PCT) levels shows promise for diagnosing bacterial infection and SIRS more accurately than individual markers alone.
Area of Science:
- Pediatric Surgery
- Transplantation Immunology
- Infectious Diseases
Background:
- Infection is a significant complication post-pediatric liver transplantation (LT).
- Timely diagnosis and treatment are vital to prevent mortality.
- Assessing biomarkers for early infection detection is critical.
Purpose of the Study:
- To evaluate the diagnostic utility of procalcitonin (PCT), white blood cell count (WBC), and C-reactive protein (CRP) for bacterial infection and SIRS in the first week after pediatric LT.
- To compare the effectiveness of these biomarkers individually and in combination.
Main Methods:
- Retrospective analysis of 88 pediatric LT patients from January 2010 to 2024.
- Collection of demographic data, vital signs, and laboratory results (PCT, CRP, WBC) on days 1, 4, and 7 post-transplant.
- Correlation of biomarker levels with culture findings and Systemic Inflammatory Response Syndrome (SIRS) criteria.
Main Results:
- SIRS was present in 17% of patients, with bacterial growth in 80% of those with SIRS.
- Elevated PCT levels were observed on days 1, 4, and 7 in patients with SIRS and bacterial growth.
- Combined body temperature and PCT on day 1 showed high sensitivity and specificity for bacterial growth and SIRS.
- Cirrhotic patients showed a blunted WBC response to infection.
Conclusions:
- PCT, CRP, and WBC alone are insufficient for diagnosing post-LT infection.
- A combined assessment of body temperature and PCT levels may improve diagnostic accuracy.
- Continuous monitoring of cultures, clinical signs, and serial physical exams is essential for effective infection management.
Abstract:
Background/Objectives: Infection is a major complication during the early postoperative period following pediatric liver transplantation (LT). Prompt diagnosis and treatment are essential to prevent death. We aimed to assess the diagnostic value of procalcitonin (PCT), white blood cell count (WBC), and C-reactive protein (CRP) levels for detecting bacterial infection and SIRS within the first week after LT. Methods: Demographic data, vital signs, laboratory results (PCT, CRP, WBC), and culture findings on the 1st, 4th, and 7th days between January 2010 and 2024 were collected retrospectively. Results: The study included 88 patients. Seventy-two percent had cirrhotic liver disease. SIRS was present in 17% (n = 15), and bacterial growth was detected in 20% (n = 18). Bacterial growth was found in 80% of patients with SIRS (n = 12/15) and in 8% of SIRS-negative patients (n = 6/73). PCT levels were significantly elevated on days 1, 4, and 7, and CRP levels on days 4 and 7 in patients with SIRS. PCT elevation was significant on days 1, 4, and 7, while WBC increase was noted on day 7 in patients with bacterial growth. Body temperature ≥ 37.1 °C and PCT ≥ 5.1 ng/dL on the first day together showed a sensitivity of 72.2% and specificity of 84.3% for bacterial growth. Similarly, body temperature ≥ 37.1 °C and PCT ≥ 9.2 ng/dL on the first day yielded 73% sensitivity and 95% specificity for diagnosing SIRS. Cirrhotic patients exhibited limited or no WBC response to bacterial growth. Conclusions: PCT, CRP, and WBC alone are insufficient for diagnosing infection. Combined assessment of body temperature changes and PCT elevation may serve as more accurate indicators. Nonetheless, close monitoring of culture results and clinical signs, with serial physical exams, can aid timely infection management or prevent unnecessary antibiotic adjustments.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test


